Patents Assigned to Orasomol Technologies, Inc.
  • Patent number: 6511677
    Abstract: The invention relates to an oral drug delivery system which delivers biologically active substances to the mucosal tissue of the intestine utilizing novel polymerized liposomes. Novel polymerizable fatty acids having a polymerizable group, a surfactant group, and a functional group, and optionally coupled to ligands which target mucosal tissue in the intestine are disclosed. Novel negatively charged polymerizable lipids which have phosphatidyl inositol (PI), phosphatidyl glycerol (PG) or phosphatidyl serine (PS) groups on a polymerizable backbone are also described.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: January 28, 2003
    Assignee: Orasomol Technologies, Inc.
    Inventors: Robert N Brey, Likan Liang
  • Patent number: 6500453
    Abstract: The invention relates to an oral drug delivery system which delivers biologically active substances to the mucosal tissue of the intestine utilizing novel polymerized liposomes. Novel polymerizable fatty acids having a polymerizable group, a surfactant group, and a functional group, and optionally coupled to ligands which target mucosal tissue in the intestine are disclosed. Novel negatively charged polymerizable lipids which have phosphatidyl inositol (PI), phosphatidyl glycerol (PG) or phosphatidyl serine (PS) groups on a polymerizable backbone are also described.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: December 31, 2002
    Assignee: Orasomol Technologies, Inc.
    Inventors: Robert N Brey, Likan Liang